Xiamen Boson Biotech Co.

What Xiamen Boson Biotech Co. does

Xiamen Boson Biotech Co., Ltd. is a Chinese in vitro diagnostic (IVD) manufacturer founded in 2001 and headquartered in the Jimei North Industrial Park of Xiamen, operating from a 12,500 square meter facility certified to ISO 13485:2016 and GMP. The company develops and manufactures point-of-care and quantitative immunoassay products across six technology platforms: colloidal gold rapid tests, quantum dot fluorescence immunoassays (R&D begun 2016, commercialized 2019), chemiluminescence immunoassays, molecular diagnostic reagents, supporting instruments, and biological raw materials (antibodies and antigens produced in-house). Its portfolio spans 100+ diagnostic solutions covering infectious diseases (HIV, HBV, HCV, SARS-CoV-2, Dengue, Malaria, Tuberculosis), drugs of abuse, cardiac and cerebral markers, tumor markers, fertility hormones, thyroid function, and inflammation. Notable instruments include the QDS-300A and hand-held QDS-200A fluorescence analyzers, the Boson-3000 chemiluminescence analyzer (up to 200 tests/hour), and the newly launched Drug Colloidal Gold Analyzer with built-in optical interpretation.

The company operates a multi-channel B2B and B2B2C model. Direct sales run through a multilingual corporate website (13 languages) with sales representatives responding to inquiries within 24 hours. Distribution is handled via a network of regional distributors in 80+ countries (U.S., Europe, Africa, Middle East, Southeast Asia), recruited and cultivated at trade exhibitions including MEDICA in Düsseldorf, Medical Philippines, and WHX Kuala Lumpur, with the company having exhibited in 30+ countries. A third motion is OEM/ODM manufacturing for private-label partners in the United States, Germany, Italy, the United Kingdom, South Korea, and Australia, with ~30-day lead times versus ~2 weeks for standard Boson-brand products. End customers include hospitals, clinics, and clinical laboratories, blood banks and transfusion services, OEM/private-label resellers, and individual consumers purchasing over-the-counter self-tests (HIV, HBV, SARS-CoV-2, pregnancy, DOA) under the "HomeScan" sub-brand.

Boson's product certifications include China NMPA/CFDA, US FDA (including EUA for SARS-CoV-2 antigen), European CE, Health Canada, Brazil ANVISA, and MDSAP (received February 2023). The company holds 17 patents, was among the first in China to receive CFDA approval for Dengue IgG/IgM in 2014, and has been recognized as a National Key "Specialized, Refined, Unique and Innovative" Enterprise, a Fujian Province Science and Technology Small Giant, and a BRICS Demonstration Unit. It remains privately held with no disclosed external institutional investment or parent company.

Name

Xiamen Boson Biotech Co.

Legal name

Xiamen Boson Biotech Co., Ltd.

Website

https://bosonbio.com

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

51–100 employees

Short description

Xiamen Boson Biotech Co., Ltd. is a Chinese IVD manufacturer founded in 2001 producing colloidal gold rapid tests, quantum dot fluorescence, chemiluminescence immunoassays, instruments, and biological raw materials for healthcare providers, distributors, OEM partners, and consumers across 80+ countries.

Ownership category

akta.pro rank

Product category

In Vitro Diagnostics

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

SIC

In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

IVD Reagents, Assay Kits & Consumables (Non-instrument) (HLAHAAAM)

akta.pro secondary industries

Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI), Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls) (HLAAAMAL)

Keywords

• In vitro diagnostics
• Rapid test kits
• Immunoassay reagents
• Point-of-care testing
• Diagnostic instruments

Headquarters

HQ city

Xiamen

HQ country

China

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. IVD Rapid Test Kits Sales: Sale of rapid immunochromatography test kits for infectious diseases, drugs of abuse, cardiac markers, tumor markers, fertility hormones, and other diagnostics. Products sold in various formats (cassette, strip) and specimen types.
2. IVD Instruments and Analyzers: Sale of fluorescence analyzers and chemiluminescence analyzers including QDS-300A, QDS-200A, and Boson-3000 systems.
3. OEM/ODM Manufacturing Services: Custom manufacturing services for international clients. Boson produces products under private label or in bulk format for further processing by clients from US, Germany, Italy, UK, South Korea, Australia, and other countries.
4. Antibodies and Antigens Raw Materials: Sale of antibodies and antigens as biological raw materials for IVD reagent manufacturing.

Pricing tiers

Go-to-market motion3 records

Distribution channels3 records

Marketing channels3 records

Core offering

Xiamen Boson Biotech Co., Ltd. develops and manufactures in vitro diagnostic (IVD) kits and instruments for the global market. Its product portfolio spans colloidal gold rapid test kits, quantum dot fluorescence immunoassay reagents, chemiluminescence immunoassay reagents, and supporting analyzers, covering infectious diseases, drugs of abuse, cardiac markers, tumor markers, and fertility hormones. The company also provides OEM/ODM manufacturing services and supplies antibodies and antigens as biological raw materials.

Product overview

Xiamen Boson Biotech Co. is an in vitro diagnostic (IVD) products manufacturer offering a comprehensive portfolio of diagnostic solutions. The product portfolio consists of four main categories: (1) IVD Rapid Test Kits using immunochromatography for point-of-care qualitative testing across infectious diseases (SARS-CoV-2, HIV, HBV, HCV, Dengue, Malaria, Tuberculosis, etc.), drugs of abuse (DOA panels, barbiturates, opiates, etc.), cardiac markers (troponin, myoglobin, CK-MB), tumor markers (FOB, AFP, CEA, PSA), and fertility hormones (HCG, LH); (2) Immunofluorescence Test Kits using quantum dot fluorescence technology for quantitative detection across similar biomarker categories; (3) Chemiluminescence Immunosassay Test Kits for quantitative laboratory testing of tumor markers, diabetes markers, and thyroid function; and (4) Supporting Instruments including the QDS-300A and QDS-200A Fluorescence Analyzers, Boson 3000 Chemiluminescence Analyzer, and the newly launched Drug Colloidal Gold Analyzer with intelligent interpretation. The company also supplies Antibodies and Antigens as raw materials. The product portfolio spans 100+ diagnostic solutions covering infectious diseases, tumor markers, drugs of abuse, hormones, cardiac/cerebral diseases, and inflammation.

Differentiator

Problem solved

Functional benefit

Brands

• HomeScan: Packaging brand for at-home testing products alongside Boson brand

Products and services

• IVD Rapid Test Kits Point-of-care immunochromatographic test kits for qualitative detection of biomarkers including infectious diseases, drugs of abuse, cardiac markers, tumor markers, and fertility hormones. Available in cassette, strip, and dip device formats. Sold to hospitals, clinics, clinical laboratories, blood banks, and distributors globally.
• Immunofluorescence Test Kits Quantum dot fluorescence immunoassay reagents for quantitative detection of biomarkers including cardiac markers, tumor markers, inflammation markers, infectious diseases, thyroid function, fertility hormones, and vitamins. Used with Boson fluorescence analyzers at point of care.
• Chemiluminescence Immunoassay Test Kits CLIA reagents for quantitative laboratory detection of tumor markers, diabetes markers, thyroid function tests, and infectious disease markers. Designed for use with Boson chemiluminescence analyzers.
• QDS-300A FIA Analyzer Single-channel fluorescence immunoassay system with a 3.5-inch screen and intuitive user interface for point-of-care testing. Used with Boson immunofluorescence test kits.
• Boson 3000 Chemiluminescence Analyzer Automatic chemiluminescence analyzer with throughput of up to 200 tests per hour in a compact footprint, intended for laboratory use with Boson CLIA reagents.
• QDS-200A Hand-held FIA Analyzer Compact hand-held single-channel fluorescence immunoassay analyzer with built-in battery for portable point-of-care testing.
• Antibodies and Antigens In-house developed and produced antibodies and antigens supplied as biological raw materials for IVD reagent manufacturers.
• Drug Colloidal Gold Analyzer Newly launched analytical instrument that combines high-precision colloidal gold detection technology with an intelligent interpretation system featuring a built-in optical camera for accurate, objective test line analysis, digital result storage, and automatic test report generation.
• OEM/ODM Manufacturing Services Custom manufacturing services that produce IVD products under private label or in bulk format for international clients in the US, Germany, Italy, UK, South Korea, Australia and other countries. Boson brand packaging lead time approximately 2 weeks; OEM packaging lead time approximately 30 days.

Quantifiable outcome

• High diagnostic accuracy - 99.6% Positive Agreement, 99.7% Negative Agreement, 99.7% Accuracy for HIV tests
• +3 more outcomes

Named customers4 records

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Six partnerships are on record, tiered core.

• OEM Partners (United States)coreOEM/ Whitelabel/ Licensing PartnerBoson Biotech produces private label products for US companies, manufacturing high-quality IVD products under their branding for distribution in the US market.
• OEM Partners (Germany)coreOEM/ Whitelabel/ Licensing PartnerGerman companies source IVD products from Boson under private label arrangements, benefiting from cost-competitive manufacturing while maintaining European quality standards.
• OEM Partners (Italy)coreOEM/ Whitelabel/ Licensing PartnerItalian companies partner with Boson for private label IVD products, utilizing Boson's manufacturing capabilities for European market distribution.
• OEM Partners (United Kingdom)coreOEM/ Whitelabel/ Licensing PartnerUK companies utilize Boson's OEM services for private label diagnostic products, leveraging China's manufacturing efficiency.
• OEM Partners (South Korea)coreOEM/ Whitelabel/ Licensing PartnerSouth Korean companies partner with Boson for private label IVD products for distribution in Asian markets.
• OEM Partners (Australia)coreOEM/ Whitelabel/ Licensing PartnerAustralian companies utilize Boson's manufacturing capabilities for private label diagnostic products for Australian and Oceanic markets.

Scale indicators8 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Beijing Wantai Biological Pharmacy: Chinese IVD and biologics company with strong infectious disease rapid test portfolio including HIV, hepatitis, and dengue diagnostics — comparable product offering and OEM presence in emerging markets.
• Hangzhou AllTest Biotech: Chinese IVD manufacturer specializing in lateral flow rapid test kits for infectious diseases, drugs of abuse, and fertility, with OEM/ODM services and global distribution — directly comparable to Boson's core product portfolio.
• Innovita Biological Technology: Chinese IVD manufacturer of colloidal gold rapid tests and chemiluminescence reagents with respiratory and infectious disease focus — direct peer in the same product categories and OEM channels.
• Guangzhou Wondfo Biotech: Major Chinese POCT and IVD manufacturer offering colloidal gold rapid tests, chemiluminescence, and immunofluorescence products with global distribution — competes with Boson in the same product categories and OEM channels.
• SD Biosensor: South Korea-based IVD manufacturer of rapid diagnostic tests and immunofluorescence platforms with strong global distribution — directly comparable product mix and target customer base in infectious disease and clinical POCT.
• OraSure Technologies: US-based point-of-care diagnostic company specializing in rapid tests for HIV, HCV, and drugs of abuse — comparable product niche and OTC/self-testing channel focus.
• ACON Laboratories: US-headquartered IVD manufacturer of rapid diagnostic tests across infectious disease, fertility, drugs of abuse, and cardiac markers with global OEM presence — direct competitor in lateral flow tests and OEM/ODM services.
• Autobio Diagnostics: Chinese IVD company focused on chemiluminescence immunoassay systems, microbiology, and rapid test kits — comparable in CLIA platform development and clinical lab market overlap with Boson.

Broad incumbents

• Abbott Rapid Diagnostics: Global IVD leader with extensive rapid diagnostic test portfolio (Binax, Panbio) and broader diagnostics business — sets the competitive benchmark for global rapid test distribution and pricing.
• QuidelOrtho: Large US-based IVD company offering rapid immunoassays, Sofia analyzer platform, and broad diagnostics portfolio — competes with Boson's POCT product lines in hospital and clinical channels.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/boson-biotech-co-ltd-

Compliance9 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Xiamen Boson Biotech Co.